|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment显示文摘Spondyloarthropathies(SpA) include many different forms of inflammatory arthritis and can affect the spine(axial SpA) and/or peripheral joints(peripheral SpA) with Ankylosing spondylitis(AS) being the prototype of the former. Extraarticular manifestations, like uveitis, psoriasis and inflammatory bowel disease(IBD) are frequently observed in the setting of SpA and are, in fact, part of the SpA classification criteria. Bowel involvement seems to be the most common of these manifestations. Clinically evident IBD is observed in 6%-14% of AS patients, which is significantly more frequent compared to the general population. Besides, it seems that silent microscopic gut inflammation, is evident in around 60% in AS patients. Interestingly, occurrence of IBD has been associated with AS disease activity. For peripheral SpA, two different forms have been proposed with diverse characteristics. Of note, SpA(axial or peripheral) is more commonly observed in Crohn's disease than in ulcerative colitis. The common pathogenetic mechanisms that explain the link between IBD and SpA are still ill-defined. The role of dysregulated microbiome along with migration of T lymphocytes and other cells from gut to the joint('gut-joint' axis) has been recognized, in the context of a genetic background including associations with alleles inside or outside the human leukocyte antigen system. Various therapeutic modalities are available with monoclonal antibodies against tumour necrosis factor, interleukin-23 and interleukin-17, being the most effective. Both gastroenterologists and rheumatologists should be alert to identify the coexistence of these conditions and ideally follow-up these patients in combined clinics. | George E Fragoulis Christina Liava Dimitrios Daoussis Euangelos Akriviadis Alexandros Garyfallos Theodoros Dimitroulas | 2019 | World Journal of Gastroenterology2019,25,18: | 13 |
| 2 | Pentoxifylline improves shortterm survival in severe acute alcoholic hepatitis:a double-blind,placebo-controlled trial显示文摘 | Akriviadis E Botla R Briggs W | | 0,,: | 2 |
| 3 | Hepatitis B prophylaxis post liver transplantation with newer nucleos(t)ide analogues after hepatitis B immunoglobulin discontinuation显示文摘 | E. Cholongitas T. Vasiliadis N. Antoniadis I. Goulis V. Papanikolaou E. Akriviadis | 2012 | Transpl Infect Dis2012,,5: | 2 |
| 4 | Pentoxifylline Improves Short-term Survival in Severe Acute Alcoholic Hepatitis: A Double-Blind, Placebo-Controlled Trial显示文摘 | Evangelos Akriviadis Ravi Botla William Briggs Steven Han Telfer Reynolds Obaid Shakil | 2000 | Gastroenterology2000,,6: | 1 |
| 5 | Omtreatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients 显示文摘 | Goulis I Karatapanis S Akriviadis E | 2015 | Liver Int2015,35,5: | 1 |
| 6 | The serum-asci-tes albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites显示文摘 | Runyon BA Montano AA Akriviadis EA | 1992 | Ann Intern Med1992,117,3: | 1 |
| 7 | Serum/ascites albumin gradient:its value as a rational approach to the differential diagnosis ofascites显示文摘 | Akriviadis E Kapnias D Hadjigarivel M | 1996 | Scand J Gastroenterol1996,31,: | 1 |
| 8 | PentoxlfyRine improve short-term survival in severe acute alcoholic hepatitis:a double-blind ,placebo-controlled trial显示文摘 | AKriviadis E Botla R | 2000 | Gastrcenterology2000,119,: | 1 |
| 9 | Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis:a double-blind,placebo-controlled trial显示文摘 | AKRIVIADIS E BOTLA R BRIGGS W | 2000 | Gastroenterology2000,119,: | 1 |
| 10 | Serum/ascites albumin gradient:its value as a rational approach to the differential diagnosis of ascites显示文摘 | Akriviadis EA Kapnias D | 1996 | Scand J Gastroenterol1996,31,8: | 1 |
| 11 | The serum ascites albumin gradient is superior to the exudatetransudate concept in the differential diagnosis of ascites显示文摘 | Runyon BA Montaro AA Akriviadis EA | 1992 | Annal of Internal Medicine1992,117,7: | 1 |
| 12 | The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites显示文摘 | Runyon BA Montano AA Akriviadis EA | | 0,,: | 1 |
| 13 | Transjugular intrahepatic portosystemic shunt: A successful treatment for hepatopulmonary syndrome显示文摘 | Khaled M. Selim Evangelos A. Akriviadis Eli Zuckerman David Chen Telfer B. Reynolds | 1998 | The American Journal of Gastroenterology1998,,3: | 1 |
| 14 | The serum-ascities albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites 显示文摘 | Runyon BA Montano AA Akriviadis EA etal | 1992 | Ann Intern Med1992,117,3: | 1 |
| 15 | The serum ascites albumin gradient is superior to the exudates-transudate concept in the differential diagnosis of ascites显示文摘 | Runyon B A Montano A A Akriviadis E A | 1992 | Ann Intern Med1992,117,: | 1 |
| 16 | The ser- um ascites albumin gradient is superior to the exudat- estransudate concept in the differential diagnosis of ascites 显示文摘 | Runyon BA Montano AA Akriviadis EA | 1992 | Ann Intern Med1992,117,3: | 1 |
| 17 | Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis:a double-blind,placebo-controlled trial显示文摘 | Akriviadis E Botla R Briggs W | 2000 | Gastroenterology2000,119,6: | 1 |
| 18 | The serumascites albuming radientis superiort ot bee xudates-t ransudatec on ceptin t hed ifferentiald iagnosiso fa scites显示文摘 | Montano AA Akriviadis EA | 1992 | Ann Intern Med1992,117,3: | 1 |
| 19 | The serum ascites albumin gradient is superior to the exudates-transudate concept in the differential diagnosis of ascites显示文摘 | Runyon BA Montano AA Akriviadis EA | 1992 | Ann Intern Med1992,117,3: | 1 |
| 20 | Hepatitis B prophylaxis post liver transplantation with newer nucleos(t)ide analogues after hepatitis B immunoglobulin discontinuation显示文摘 | E. Cholongitas T. Vasiliadis N. Antoniadis I. Goulis V. Papanikolaou E. Akriviadis | 2012 | Transpl Infect Dis2012,,5: | 1 |